DocMorris shares reach 52-week high amid improved forecasts

DocMorris shares reached a 52-week high on September 30, 2026, climbing 6.3 percent to 13.18 CHF during midday trading on the SIX Swiss Exchange. This recovery follows a significant period of volatility, including a 52-week low of 3.92 CHF in March 2026.

The company has recently adjusted its financial outlook upward. Management now expects external revenue growth of 9 to 13 percent. Additionally, the forecast for adjusted EBITDA loss has been narrowed to a range of 10 to 17.5 million CHF, compared to a previous projection of a 10 to 25 million CHF loss.

DocMorris is targeting an operational turning point, aiming to reach break-even on adjusted EBITDA in the second half of the current fiscal year, with a goal to reach cash flow break-even by 2027.